Matthew Arismendez, PA-C

Matthew Arismendez practices at Kellum Medical Group, PA in San Antonio, Texas.

Matthew Arismendez's NPI, 1346646510, was assigned on November 14, 2014. Matthew Arismendez holds Texas license PA09452.

Matthew Arismendez's primary practice is Kellum Medical Group, PA, at 7323 Marbach Rd, San Antonio, TX 78227 in Bexar County. The practice phone is (210) 674-0257.

Matthew Arismendez's primary practice is Kellum Medical Group, PA in San Antonio, Texas. The medical group on file is Kellum Medical Group PA. Dmand AI also links Matthew Arismendez to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Arismendez practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Matthew Arismendez's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Matthew Arismendez is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Matthew Arismendez is licensed in Texas.

Dmand AI lists acute sinusitis, acute skin infection, anxiety, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), diabetic emergency and enlarged prostate among the conditions Matthew Arismendez treats.

CMS data shows 513 Medicare services from Matthew Arismendez across 8 procedure codes in 2024, for 99 Medicare patients. Medicare paid $14,634 for them. Every service was in an office.

CMS counts 99 Medicare patients who saw Matthew Arismendez in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Arismendez's median patient age at 63, with 52% women.

In 2024, Matthew Arismendez wrote 7,552 Medicare Part D claims for 684 patients. 86% of them were for generic drugs. CMS names the drug for 6,869 of them, across 125 drugs with 11 or more claims each, at $796,103 in total drug cost.

Matthew Arismendez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 152 general payments to Matthew Arismendez from 26 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $414.

Matthew Arismendez is a member of AAPA.